drugset / Trial / NCT05760781
To Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Phase 2
Terminated
9 enrolled
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Beijing Sanuo Jiayi Biotechnology Co. LTD · collab
Non-randomizedSequentialOpen-labelTreatment
Summary
This trial is a multi-center, open, single-dose, dose-increasing trial，to evaluate the safety and efficacy of STSG-0002 injection in patients with chronic hepatitis B treated with oral antiviral therapy.
Timeline
- Start
- 2023-04-25
- Primary completion
- 2023-12-11
- Completion
- 2023-12-11
Outcome
Outcome not reported
Stopped: “The preliminary effectiveness data observed at present did not meet the expectations, the benefit of the subjects receiving the experimental drug was limited.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | STSG-0002 | Unknown | — | Intravenous |